{
    "hands_on_practices": [
        {
            "introduction": "Understanding Chimeric Antigen Receptor (CAR) function begins with the fundamental biophysics of receptor-ligand binding. This first exercise grounds your understanding in the Law of Mass Action to derive the relationship between antigen concentration, binding affinity ($K_D$), and the resulting receptor occupancy. By calculating the fraction of engaged CARs in a hypothetical scenario , you will build the quantitative intuition needed to predict CAR sensitivity and connect molecular properties to cellular responses.",
            "id": "5005577",
            "problem": "A Chimeric Antigen Receptor (CAR) T cell expressing a monovalent single-chain variable fragment (scFv) binds a soluble monomeric ligand via the equilibrium reaction $R + L \\rightleftharpoons RL$, where $R$ denotes free receptor, $L$ denotes free ligand, and $RL$ denotes the receptor–ligand complex. Assume an isothermal, well-mixed environment in which the Law of Mass Action applies, and that the dissociation constant $K_D$ is defined by $K_D = \\frac{[R][L]}{[RL]}$. Let the total receptor concentration be $R_T = [R] + [RL]$, and define the bound fraction $f$ by $f = \\frac{[RL]}{R_T}$. Using only the stated definitions and fundamental equilibrium principles, derive an expression for $f$ in terms of $[L]$ and $K_D$ under conditions where $[L]$ denotes the free ligand concentration at equilibrium.\n\nYou are given $[L] = 10\\,\\text{nM}$ and $K_D = 100\\,\\text{nM}$. Compute the numerical value of the bound fraction $f$ using your derived expression. Round your final numerical answer to three significant figures and express it as a unitless decimal.\n\nTo connect this computation to translational design questions, consider a high-avidity context in which CAR microcluster formation and costimulatory domains reduce the effective signaling threshold per cell. For interpretability, suppose a typical CAR surface expression level of $N_R = 5.0 \\times 10^{4}$ receptors per cell. Based on your computed $f$, estimate the number of engaged receptors $N_{\\text{eng}} = f \\times N_R$ and briefly discuss, using first principles about avidity and signaling thresholds, whether this occupancy is plausibly sufficient to trigger activation in such a high-avidity context. Your qualitative interpretation will not affect the numeric answer requirement; your final reported answer must be only the bound fraction $f$ rounded as specified.",
            "solution": "The user has provided a problem that is scientifically grounded, well-posed, and objective. It is based on fundamental principles of equilibrium chemistry (the Law of Mass Action) as applied to a standard biochemical model of receptor-ligand binding (the Langmuir isotherm). All necessary definitions, constants, and conditions are provided to derive the required expression and compute the numerical result. The parameters given are realistic for the biological context of Chimeric Antigen Receptor (CAR) T cell interactions. Therefore, the problem is valid, and a full solution can be constructed.\n\nThe primary goal is to derive an expression for the bound fraction, $f$, in terms of the free ligand concentration, $[L]$, and the dissociation constant, $K_D$. The provided definitions are:\n1.  Equilibrium reaction: $R + L \\rightleftharpoons RL$\n2.  Dissociation constant: $K_D = \\frac{[R][L]}{[RL]}$\n3.  Total receptor concentration: $R_T = [R] + [RL]$\n4.  Bound fraction: $f = \\frac{[RL]}{R_T}$\n\nWe begin with the definition of the bound fraction, $f$.\n$$f = \\frac{[RL]}{R_T}$$\nSubstitute the definition of $R_T$ into this equation:\n$$f = \\frac{[RL]}{[R] + [RL]}$$\nOur goal is to express $f$ using only $[L]$ and $K_D$. To do this, we must eliminate $[R]$ and $[RL]$. We can achieve this by expressing one in terms of the other and simplifying. Let us rearrange the definition of the dissociation constant, $K_D$, to solve for the free receptor concentration, $[R]$:\n$$[R] = \\frac{K_D [RL]}{[L]}$$\nNow, we substitute this expression for $[R]$ into our equation for $f$:\n$$f = \\frac{[RL]}{\\left(\\frac{K_D [RL]}{[L]}\\right) + [RL]}$$\nThe term $[RL]$ is a common factor in the denominator. We can factor it out:\n$$f = \\frac{[RL]}{[RL] \\left(\\frac{K_D}{[L]} + 1\\right)}$$\nAssuming that some binding occurs ($[RL] > 0$), we can cancel the $[RL]$ term from the numerator and the denominator:\n$$f = \\frac{1}{\\frac{K_D}{[L]} + 1}$$\nTo simplify the compound fraction, we can multiply the numerator and the denominator by $[L]$:\n$$f = \\frac{1 \\cdot [L]}{\\left(\\frac{K_D}{[L]} + 1\\right) \\cdot [L]} = \\frac{[L]}{K_D + [L]}$$\nThis is the final derived expression for the bound fraction $f$ in terms of $[L]$ and $K_D$. This is a form of the Hill-Langmuir equation for a system with a Hill coefficient of $1$.\n\nNext, we are asked to compute the numerical value of $f$ given $[L] = 10\\,\\text{nM}$ and $K_D = 100\\,\\text{nM}$. We substitute these values into our derived expression:\n$$f = \\frac{10\\,\\text{nM}}{100\\,\\text{nM} + 10\\,\\text{nM}}$$\nThe units of concentration (nM) cancel out, as expected for a dimensionless fraction:\n$$f = \\frac{10}{110} = \\frac{1}{11}$$\nTo provide a decimal answer rounded to three significant figures, we perform the division:\n$$f = \\frac{1}{11} \\approx 0.09090909...$$\nRounding to three significant figures yields:\n$$f \\approx 0.0909$$\n\nFor the interpretive part of the question, we first calculate the number of engaged receptors, $N_{\\text{eng}}$, per cell. Given a total receptor number $N_R = 5.0 \\times 10^{4}$ receptors/cell:\n$$N_{\\text{eng}} = f \\times N_R \\approx 0.0909 \\times (5.0 \\times 10^{4}) \\approx 4545\\,\\text{receptors}$$\nThe question is whether this occupancy is plausibly sufficient for activation in a high-avidity context. T cell activation requires a signal to surpass a certain threshold. This threshold is not a fixed number of engaged receptors but is modulated by several factors. In a \"high-avidity context\" with CARs, several principles apply:\n1.  **Multivalency**: High avidity implies that multiple CARs on the T cell surface are binding to multiple ligands on a target cell, creating a stable immunological synapse. This is a much more potent stimulus than binding to a soluble, monomeric ligand.\n2.  **Signal Integration and Amplification**: CARs cluster into micro-domains upon binding, concentrating signaling molecules and amplifying the downstream signal from each engaged receptor.\n3.  **Costimulation**: The intracellular domains (e.g., from CD28 or 4-1BB) in modern CARs provide costimulatory signals that are essential for full T cell activation and significantly lower the activation threshold compared to T-cell receptors (TCRs) alone.\n\nGiven these principles, the engagement of approximately $4500$ receptors is well above the minimal numbers often cited for T cell activation (which can be as low as a few dozen to a few hundred under optimal conditions). Even though the fractional occupancy is low (approximately $9.1\\%$), the absolute number of engaged receptors, amplified by the high-avidity binding environment and engineered costimulation, makes it highly plausible that this level of occupancy is sufficient to trigger robust CAR-T cell activation.",
            "answer": "$$\\boxed{0.0909}$$"
        },
        {
            "introduction": "Effective CAR-T therapy requires not just potent on-tumor activity but also exquisite safety, minimizing harm to healthy tissues. This practice  explores a key strategy for achieving this: engineering pH-dependent affinity to exploit the acidic tumor microenvironment. You will apply the principle of fractional occupancy to calculate a selectivity ratio, providing a quantitative measure of how this design creates a crucial therapeutic window between tumor and healthy tissue.",
            "id": "5005523",
            "problem": "A translational program is developing a pH-switch engineered Chimeric Antigen Receptor (CAR) T cell whose single-chain variable fragment (scFv) exhibits pH-dependent affinity to a membrane antigen that is present in both tumor and healthy tissues. The scFv has been engineered such that, at the acidic extracellular pH characteristic of many solid tumors, its dissociation constant is lower (higher affinity), while at the neutral pH of healthy tissue it is higher (lower affinity). In a controlled biophysical characterization, the dissociation constants were measured to be $K_D^{\\mathrm{tumor}} = 3.7\\,\\mathrm{nM}$ at pH $6.8$ and $K_D^{\\mathrm{healthy}} = 135\\,\\mathrm{nM}$ at pH $7.4$.\n\nUsing only the law of mass action and the definition of the dissociation constant, define the binding selectivity ratio as the ratio of the expected CAR–antigen fractional occupancies between tumor and healthy contexts when probed at an identical antigen level small enough that the linear (low-ligand) regime applies. Compute this binding selectivity ratio $S$ from the given $K_D$ values. Report $S$ as a dimensionless number rounded to three significant figures.\n\nThen, using the same foundational principles, reason whether this affinity selectivity is likely sufficient for on-tumor activation with off-tumor sparing if the effective antigen concentrations at the immunological synapse are approximately $[A]_{\\mathrm{tumor}} = 5.0\\,\\mathrm{nM}$ and $[A]_{\\mathrm{healthy}} = 0.50\\,\\mathrm{nM}$, and if the CAR activation threshold requires a steady-state fractional occupancy of at least $\\theta^{\\ast} = 0.10$. For the discussion, express any intermediate quantities you compute in nanomolar (nM) for concentrations and as pure decimals for fractional occupancies. The discussion does not change the required final numeric answer for $S$.",
            "solution": "The problem statement has been validated and is deemed scientifically grounded, well-posed, and internally consistent. It is based on established principles of receptor-ligand binding kinetics and their application to a realistic problem in translational immunotherapy. All necessary data and definitions are provided to arrive at a unique, meaningful solution.\n\nThe foundational principle for this problem is the law of mass action applied to a reversible receptor-ligand binding event. For a Chimeric Antigen Receptor (CAR), denoted $C$, binding to its target antigen, $A$, the equilibrium is described by:\n$$\nC + A \\rightleftharpoons CA\n$$\nwhere $CA$ is the bound complex. The dissociation constant, $K_D$, is defined at equilibrium by the ratio of concentrations:\n$$\nK_D = \\frac{[C][A]}{[CA]}\n$$\nThe fractional occupancy, $\\theta$, of the CAR is the fraction of the total CAR population that is bound to the antigen. It is given by:\n$$\n\\theta = \\frac{[CA]}{[C]_{\\text{total}}} = \\frac{[CA]}{[C] + [CA]}\n$$\nBy rearranging the $K_D$ definition to $[C] = \\frac{K_D [CA]}{[A]}$ and substituting it into the expression for $\\theta$, we derive the standard Langmuir isotherm for monovalent binding:\n$$\n\\theta = \\frac{[CA]}{\\frac{K_D [CA]}{[A]} + [CA]} = \\frac{1}{\\frac{K_D}{[A]} + 1} = \\frac{[A]}{[A] + K_D}\n$$\n\nThe first part of the problem asks for the binding selectivity ratio, $S$, defined as the ratio of fractional occupancies in the tumor versus healthy context, under the specific condition of the \"linear (low-ligand) regime.\" This regime is defined by the condition that the antigen concentration is much smaller than the dissociation constant, i.e., $[A] \\ll K_D$. Under this approximation, the denominator of the fractional occupancy equation simplifies to $[A] + K_D \\approx K_D$. The fractional occupancy becomes:\n$$\n\\theta \\approx \\frac{[A]}{K_D}\n$$\nThe selectivity ratio $S$ is the ratio of $\\theta_{\\mathrm{tumor}}$ to $\\theta_{\\mathrm{healthy}}$ at an identical antigen concentration $[A]$ in this linear regime.\n$$\nS = \\frac{\\theta_{\\mathrm{tumor}}}{\\theta_{\\mathrm{healthy}}} = \\frac{[A]/K_D^{\\mathrm{tumor}}}{[A]/K_D^{\\mathrm{healthy}}}\n$$\nThe antigen concentration $[A]$ cancels, yielding a selectivity ratio that depends only on the dissociation constants:\n$$\nS = \\frac{K_D^{\\mathrm{healthy}}}{K_D^{\\mathrm{tumor}}}\n$$\nUsing the provided values, $K_D^{\\mathrm{tumor}} = 3.7\\,\\mathrm{nM}$ and $K_D^{\\mathrm{healthy}} = 135\\,\\mathrm{nM}$:\n$$\nS = \\frac{135}{3.7} \\approx 36.486486...\n$$\nRounding to three significant figures, the binding selectivity ratio is $36.5$. This dimensionless number indicates that, in the low-antigen limit, the CAR is approximately $36.5$ times more likely to be bound in the acidic tumor environment than in the neutral healthy tissue environment for the same antigen concentration.\n\nThe second part of the problem asks for an assessment of whether this selectivity is sufficient for differential activation, given specific antigen concentrations and an activation threshold. For this analysis, we must use the full, non-approximated equation for fractional occupancy, as the antigen concentrations may not be in the linear regime. The activation threshold is given as $\\theta^{\\ast} = 0.10$.\n\nIn the tumor context:\nThe antigen concentration is $[A]_{\\mathrm{tumor}} = 5.0\\,\\mathrm{nM}$ and the dissociation constant is $K_D^{\\mathrm{tumor}} = 3.7\\,\\mathrm{nM}$. The fractional occupancy is:\n$$\n\\theta_{\\mathrm{tumor}} = \\frac{[A]_{\\mathrm{tumor}}}{[A]_{\\mathrm{tumor}} + K_D^{\\mathrm{tumor}}} = \\frac{5.0}{5.0 + 3.7} = \\frac{5.0}{8.7} \\approx 0.575\n$$\nThis fractional occupancy, $0.575$, is greater than the activation threshold $\\theta^{\\ast} = 0.10$. Therefore, robust activation of the CAR T-cells is expected in the tumor microenvironment.\n\nIn the healthy tissue context:\nThe antigen concentration is $[A]_{\\mathrm{healthy}} = 0.50\\,\\mathrm{nM}$ and the dissociation constant is $K_D^{\\mathrm{healthy}} = 135\\,\\mathrm{nM}$. The fractional occupancy is:\n$$\n\\theta_{\\mathrm{healthy}} = \\frac{[A]_{\\mathrm{healthy}}}{[A]_{\\mathrm{healthy}} + K_D^{\\mathrm{healthy}}} = \\frac{0.50}{0.50 + 135} = \\frac{0.50}{135.5} \\approx 0.00369\n$$\nThis fractional occupancy, approximately $0.0037$, is substantially less than the activation threshold $\\theta^{\\ast} = 0.10$. Therefore, the CAR T-cells are not expected to be activated in healthy tissue, achieving the goal of \"off-tumor sparing.\"\n\nIn conclusion, the combination of pH-dependent affinity tuning and the differing antigen concentrations between tumor and healthy tissues creates a scenario where the CAR T-cell is predicted to be active on the tumor ($\\theta_{\\mathrm{tumor}} > \\theta^{\\ast}$) but quiescent in healthy tissue ($\\theta_{\\mathrm{healthy}} < \\theta^{\\ast}$). The designed selectivity appears sufficient to establish a therapeutic window under these model conditions. The final required answer is the numerical value for $S$.",
            "answer": "$$\\boxed{36.5}$$"
        },
        {
            "introduction": "The concept of affinity is more nuanced than the equilibrium dissociation constant ($K_D$) alone suggests. In this advanced problem , you will dissect affinity into its kinetic components ($k_{\\text{on}}$ and $k_{\\text{off}}$) to analyze a common clinical challenge: a soluble decoy antigen that can sequester CAR-T cells before they reach the tumor. By comparing high- and low-affinity CARs, you will learn how tuning binding kinetics and considering bond dwell times are critical for designing therapies that resist this sequestration and maintain potent activity against membrane-bound targets.",
            "id": "5005541",
            "problem": "A Chimeric Antigen Receptor (CAR) is a synthetic receptor that binds a target antigen and transduces an activation signal when sufficient receptors are engaged at the T cell–tumor cell interface for a sufficient dwell time. From the law of mass action for receptor–ligand binding at equilibrium, the fractional occupancy $\\theta$ in three dimensions is given by $\\theta = \\dfrac{[L]}{K_D + [L]}$, where $[L]$ is the free ligand concentration and $K_D = \\dfrac{k_{\\text{off}}}{k_{\\text{on}}}$ is the equilibrium dissociation constant with $k_{\\text{on}}$ the association rate and $k_{\\text{off}}$ the dissociation rate. In two-dimensional contacts such as the immunological synapse, high membrane antigen density effectively increases local encounter rates and multivalent binding can create avidity, but individual bonds still have lifetimes governed by $k_{\\text{off}}$ and occupancy can be approximated by the same mass-action form using an effective local concentration.\n\nConsider two engineered CARs against the same antigen, with identical intracellular signaling domains and identical association rates, but different binding affinities: a high-affinity CAR (CAR-H) with $K_D^{H} = 1\\,\\mathrm{nM}$ and a lower-affinity CAR (CAR-L) with $K_D^{L} = 100\\,\\mathrm{nM}$. Both have $k_{\\text{on}} = 10^{6}\\,\\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$, so $k_{\\text{off}}^{H} = 10^{-3}\\,\\mathrm{s}^{-1}$ and $k_{\\text{off}}^{L} = 10^{-1}\\,\\mathrm{s}^{-1}$. A T cell expresses $R = 1.0 \\times 10^{5}$ CAR molecules on its surface.\n\nYou are told that in the blood the soluble antigen is monomeric at $[A_s] = 50\\,\\mathrm{nM}$, and at the T cell–tumor cell interface the membrane antigen achieves an effective local concentration of $[A_m^{\\text{eff}}] = 500\\,\\mathrm{nM}$ due to high surface density and confinement. Activation requires at least $N_{\\text{th}} = 2.0 \\times 10^{4}$ simultaneously engaged CARs sustained for at least $t_{\\text{min}} = 2\\,\\mathrm{s}$.\n\nBased on these physically grounded definitions and parameters, choose the option that best predicts whether lowering affinity can reduce sequestration by soluble antigen while maintaining activation on high-density membrane targets.\n\nA. Lowering affinity to CAR-L reduces soluble sequestration while maintaining activation at the membrane interface, because $R \\theta_{m}^{L} \\ge N_{\\text{th}}$ and $\\dfrac{1}{k_{\\text{off}}^{L}} \\ge t_{\\text{min}}$, whereas $R \\theta_{s}^{L}$ is substantially lower than for CAR-H.\n\nB. Lowering affinity to CAR-L fails to maintain activation, because its bond lifetime $\\dfrac{1}{k_{\\text{off}}^{L}}$ is too short to meet $t_{\\text{min}}$ even at high membrane antigen density.\n\nC. Lowering affinity to CAR-L does not reduce soluble sequestration, because $\\theta$ depends only on $k_{\\text{on}}$ and not on $K_D$ at fixed ligand concentration.\n\nD. Lowering affinity to CAR-L increases sequestration by soluble antigen relative to CAR-H, because increasing $K_D$ increases occupancy $\\theta$ at a fixed $[A_s]$.",
            "solution": "We start from the law of mass action for receptor–ligand binding at equilibrium, which gives the fractional occupancy $\\theta = \\dfrac{[L]}{K_D + [L]}$. For soluble antigen in three dimensions at $[A_s] = 50\\,\\mathrm{nM}$, the occupancy for CAR-H and CAR-L are\n$$\n\\theta_{s}^{H} = \\frac{50}{1 + 50} \\approx \\frac{50}{51} \\approx 0.98,\n$$\n$$\n\\theta_{s}^{L} = \\frac{50}{100 + 50} = \\frac{50}{150} \\approx 0.33.\n$$\nThus, for soluble antigen, CAR-L exhibits substantially reduced occupancy compared to CAR-H. The number of CARs sequestered by soluble antigen under equilibrium is $R \\theta$, giving\n$$\nR \\theta_{s}^{H} \\approx (1.0 \\times 10^{5})(0.98) \\approx 9.8 \\times 10^{4},\n$$\n$$\nR \\theta_{s}^{L} \\approx (1.0 \\times 10^{5})(0.33) \\approx 3.3 \\times 10^{4}.\n$$\nTherefore, lowering affinity substantially reduces soluble sequestration, cutting the occupied fraction by approximately two-thirds compared to CAR-H.\n\nNext, consider the membrane interface where high antigen density and confinement yield an effective local concentration $[A_m^{\\text{eff}}] = 500\\,\\mathrm{nM}$. Using the same occupancy form to approximate two-dimensional engagement (the difference being reflected in the effective local concentration),\n$$\n\\theta_{m}^{H} = \\frac{500}{1 + 500} \\approx \\frac{500}{501} \\approx 0.998,\n$$\n$$\n\\theta_{m}^{L} = \\frac{500}{100 + 500} = \\frac{500}{600} \\approx 0.83.\n$$\nThe number of engaged CARs at the synapse is\n$$\nR \\theta_{m}^{H} \\approx (1.0 \\times 10^{5})(0.998) \\approx 9.98 \\times 10^{4},\n$$\n$$\nR \\theta_{m}^{L} \\approx (1.0 \\times 10^{5})(0.83) \\approx 8.3 \\times 10^{4}.\n$$\nThe activation threshold requires at least $N_{\\text{th}} = 2.0 \\times 10^{4}$ simultaneously engaged CARs. Both CAR-H and CAR-L exceed this threshold at the membrane interface:\n$$\nR \\theta_{m}^{L} \\approx 8.3 \\times 10^{4} > 2.0 \\times 10^{4}.\n$$\nAdditionally, the dwell time criterion must be met. The bond lifetimes are\n$$\n\\tau_{H} = \\frac{1}{k_{\\text{off}}^{H}} = \\frac{1}{10^{-3}\\,\\mathrm{s}^{-1}} = 10^{3}\\,\\mathrm{s},\n$$\n$$\n\\tau_{L} = \\frac{1}{k_{\\text{off}}^{L}} = \\frac{1}{10^{-1}\\,\\mathrm{s}^{-1}} = 10\\,\\mathrm{s}.\n$$\nSince $t_{\\text{min}} = 2\\,\\mathrm{s}$, both lifetimes exceed the minimum required dwell time, and in particular $\\tau_{L} = 10\\,\\mathrm{s} \\ge 2\\,\\mathrm{s}$. Therefore, CAR-L can maintain activation at the membrane interface despite lower affinity.\n\nOption-by-option analysis:\n\nA. This option claims that CAR-L reduces soluble sequestration while maintaining activation at the membrane interface because $R \\theta_{m}^{L} \\ge N_{\\text{th}}$ and $\\dfrac{1}{k_{\\text{off}}^{L}} \\ge t_{\\text{min}}$, and that $R \\theta_{s}^{L}$ is substantially lower than for CAR-H. Our calculations show $R \\theta_{s}^{L} \\approx 3.3 \\times 10^{4}$ compared to $R \\theta_{s}^{H} \\approx 9.8 \\times 10^{4}$ (reduced sequestration), $R \\theta_{m}^{L} \\approx 8.3 \\times 10^{4} \\ge 2.0 \\times 10^{4}$ (exceeds threshold), and $\\dfrac{1}{k_{\\text{off}}^{L}} = 10\\,\\mathrm{s} \\ge 2\\,\\mathrm{s}$ (meets dwell time). Verdict — Correct.\n\nB. This option asserts failure because $\\dfrac{1}{k_{\\text{off}}^{L}}$ is too short. However, $\\dfrac{1}{k_{\\text{off}}^{L}} = 10\\,\\mathrm{s}$, which exceeds $t_{\\text{min}} = 2\\,\\mathrm{s}$. Moreover, high occupancy at the membrane further supports activation. Verdict — Incorrect.\n\nC. This option asserts that occupancy depends only on $k_{\\text{on}}$ and not $K_D$ at fixed $[L]$. From $\\theta = \\dfrac{[L]}{K_D + [L]}$ with $K_D = \\dfrac{k_{\\text{off}}}{k_{\\text{on}}}$, occupancy depends on $K_D$ and not solely on $k_{\\text{on}}$. With identical $k_{\\text{on}}$ for both CARs, increasing $K_D$ (via increased $k_{\\text{off}}$) decreases $\\theta$ at fixed $[L]$. Our calculations confirm reduced $\\theta$ for CAR-L in soluble antigen. Verdict — Incorrect.\n\nD. This option claims that increasing $K_D$ increases $\\theta$ at fixed $[A_s]$. The mass-action relationship shows the opposite: increasing $K_D$ decreases $\\theta$ at fixed $[L]$. Our computed $\\theta_{s}^{L} \\approx 0.33$ is lower than $\\theta_{s}^{H} \\approx 0.98$. Verdict — Incorrect.\n\nTherefore, the data and first-principles analysis support that lowering affinity can reduce sequestration by soluble antigen while maintaining activation on high-density membrane targets in this scenario, consistent with option A.",
            "answer": "$$\\boxed{A}$$"
        }
    ]
}